|
KARS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.744200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.046360E-02 |
| Normal-vs-Stage2 |
1.785000E-01 |
| Normal-vs-Stage3 |
9.414400E-04 |
| Normal-vs-Stage4 |
2.655800E-02 |
| Stage1-vs-Stage2 |
6.847600E-01 |
| Stage1-vs-Stage3 |
2.069000E-01 |
| Stage1-vs-Stage4 |
5.662400E-01 |
| Stage2-vs-Stage3 |
2.025600E-01 |
| Stage2-vs-Stage4 |
4.482600E-01 |
| Stage3-vs-Stage4 |
7.328600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.537700E-03 |
| Normal-vs-AfricanAmerican |
3.774200E-01 |
| Normal-vs-Asian |
7.100200E-02 |
| Caucasian-vs-AfricanAmerican |
4.084800E-01 |
| Caucasian-vs-Asian |
5.677800E-01 |
| AfricanAmerican-vs-Asian |
6.273600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.542300E-03 |
| Normal-vs-Female |
3.980100E-03 |
| Male-vs-Female |
9.463000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.244400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.316000E-03 |
| Normal-vs-Age(61-80Yrs) |
6.277800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.133600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.957800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.263600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.400600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.102000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.381240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.298780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.962600E-01 |
| Classical-VS-Follicular |
1.771530E-04 |
| Classical-VS-Other |
3.958800E-01 |
| Classical-VS-Normal |
7.703900E-02 |
| Tall-VS-Follicular |
3.625800E-02 |
| Tall-VS-Other |
6.330800E-01 |
| Tall-VS-Normal |
6.265600E-02 |
| Follicular-VS-Other |
5.978600E-01 |
| Follicular-VS-Normal |
1.55423000000043E-05 |
| Other-VS-Normal |
3.031400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.116890E-03 |
| Normal-vs-N1 |
9.363500E-04 |
| N0-vs-N1 |
1.397010E-01 |
|
|
